# A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer

> **NCT04951154** · — · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 33 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **OTHER:** Bronchoscopic Biopsy
- **OTHER:** Blood Sample

## Key facts

- **NCT ID:** NCT04951154
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-28
- **Primary completion:** 2023-05-15
- **Final completion:** 2023-05-15
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2025-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04951154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04951154, "A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT04951154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*